Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (342)	1/8/1998 12:30:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 353

<<<<<So it is done. ...mr. walker has his integrated biotech company. no need to have envy of millenium anymore--but will the stock go up? i will watch before i make any bigger bets on arris.

To: Miljenko Zuanic who wrote (342)	1/8/1998 1:36:00 AM
From: John Metcalf	Read Replies (1) \| Respond to of 353

Miljenko, this may not be a clear explanation, but it does contain some facts that may be useful: Short interest in Arris was 1,487,722 shares in the December report (mid month). This represented 10% of shares outstanding, or about 8 days of average volume. (SQNA short interest was insignificant at 60,130 shares.) Covering should push up the price somewhat. Particularly so because short sales had increased by a magnitude of ten since September-October.